A composite score including BMI liver stiffness and rs738409 PNPLA3 genotype might spare liver biopsies to most NAFLD patients maintaining 95% diagnostic accuracy
Michela Emma Burlone(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mario Pirisi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrea Magrì(Centre for Human Genetics), Monica Leutner(ASL Roma), C Fabris, Pierluigi Toniutto(University of Udine), C. Colletta, Rosalba Minisini, Angelo Rossini(Centro Universitário Barão de Mauá), E Momo
Unknown
January 1, 2012
Cited by 3
Related Papers
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge
|JAMA Network Open|2021|493
SAFE biopsy
|Hepatology|2009|183
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus
|Nature Genetics|2017|149
Correction: Corrigendum: Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication
|Scientific Reports|2016|144
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133